Anja Monika Wittke

US Patent:

20210235740, Aug 5, 2021

Filed:

Apr 19, 2021

Appl. No.:

17/233716

Inventors:

- Evansville IN, US
Cindy van Bommel - Zaltbommel, NL
Zihua Ao - Newburgh IN, US
Anja Wittke - Boston MA, US
Kelly Alina Dingess - Nijmegen, NL
Kasper Hettinga - Wageningen, NL

Assignee:

MEAD JOHNSON NUTRITION COMPANY - Evansville IN

International Classification:

A23L 33/00
A23L 33/18
A23L 33/19
A23J 3/34
A61K 38/01

Abstract:

The present disclosure generally relates to methods of preparing protein hydrolysates for use in pediatric nutritional compositions. Specifically, alpha-, beta- and/or kappa casein enriched casein, acid casein or caseinates can be hydrolyzed with proteases such as trypsin (trypsin-like), chymotrypsin (chymotrypsin-like), pepsin and/or plasmin to produce a hydrolysate that is close to the peptide composition of human breast milk.

US Patent:

20200260773, Aug 20, 2020

Filed:

Sep 5, 2018

Appl. No.:

16/642656

Inventors:

- Evansville IN, US
Teartse Tim Lambers - Nijmegen, NL
Anja Monika Wittke - Alexandria VA, US

International Classification:

A23L 33/00
A23L 33/12
A23L 33/135
A23L 33/18
A23L 33/19
A23L 33/21

Abstract:

Provided are nutritional compositions having a decreased protein content. Further disclosed are nutritional composition having a protein or protein equivalent source that includes intact protein, beta-casein enriched casein hydrolysate, and/or amino acids. The nutritional compositions disclosed are suitable for administration to pediatric subjects, such as infants.

US Patent:

20180160715, Jun 14, 2018

Filed:

Dec 12, 2016

Appl. No.:

15/376432

Inventors:

- Glenview IL, US
Cindy van Bommel - Zaltbommel, NL
Zihua Ao - Newburgh IN, US
Anja Wittke - Boston MA, US
Kelly Alina Dingess - Nijmegen, NL
Kasper Hettinga - Wageningen, NL

International Classification:

A23L 33/00
A23L 33/18
A23L 33/19
A23L 33/115
A23L 33/12
A23L 33/155
A23L 33/15
A23L 33/16

Abstract:

The present disclosure generally relates to methods of preparing protein hydrolysates for use in pediatric nutritional compositions. Specifically, alpha-, beta- and/or kappa casein enriched casein, acid casein or caseinates can be hydrolyzed with proteases such as trypsin (trypsin-like), chymotrypsin (chymotrypsin-like), pepsin and/or plasmin to produce a hydrolysate that is close to the peptide composition of human breast milk.

US Patent:

20150231213, Aug 20, 2015

Filed:

Mar 3, 2015

Appl. No.:

14/636810

Inventors:

- Glenview IL, US
Brian Berg - Evansville IN, US
Zeina Jouni - Battle Creek MI, US
Anja Wittke - Boston MA, US
Rosaline Waworuntu - Evansville IN, US

International Classification:

A61K 38/48
A23L 1/308
A61K 31/702
A23L 1/305
A61K 31/715
A23L 1/29
A23L 1/30

Abstract:

Provided is a composition and method for modulating serotonergic receptor expression, reducing anxiety-like behavior and stress-induced inflammatory response in a pediatric subject, the method including administering to the pediatric subject a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides. Further provided is a method for reducing constipation in a pediatric subject by providing a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides.

US Patent:

20150125570, May 7, 2015

Filed:

Jan 16, 2015

Appl. No.:

14/598700

Inventors:

- Glenview IL, US
Anja Wittke - Boston MA, US

International Classification:

A23L 1/29

US Classification:

426 2

Abstract:

The present disclosure relates to milk-based nutritional compositions comprising lactoferrin and/or a prebiotic component, wherein, when combined, the lactoferrin and prebiotic component may exhibit additive or synergistic beneficial effects on the health and development of a pediatric subject. The disclosure further relates to methods comprising the administration of said milk-based nutritional compositions to pediatric subjects.

US Patent:

20150119322, Apr 30, 2015

Filed:

Nov 7, 2014

Appl. No.:

14/535717

Inventors:

- Glenview IL, US
Brian Berg - Evansville IN, US
Zeina Jouni - Battle Creek MI, US
Anja Wittke - Boston MA, US
Rosaline Waworuntu - Evansville IN, US

International Classification:

A61K 38/40
A61K 31/715
A61K 31/202
A61K 31/7048
A61K 31/661
A23L 1/308
A61K 31/702

US Classification:

514 55

Abstract:

Provided is a composition and method for modulating serotonergic receptor expression, reducing anxiety-like behavior and stress-induced inflammatory response in a pediatric subject, the method including administering to the pediatric subject a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides. Further provided is a method for reducing constipation in a pediatric subject by providing a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides.